As ERK1/2 has both nuclear and cytoplasmic substrates (Widmann et al, 1999), this observation could indicate an important role of cytoplasmic substrates of ERK1/2 in advanced and metastatic tumours. This evidence concerns the gene MAPK3 and metastatic neoplasm.